Wei Chang Zhou
Directeur/Membre du Conseil chez WUXI BIOLOGICS (CAYMAN) INC.
Fortune : 714 532 $ au 30/06/2024
Profil
Wei Chang Zhou is a Non-Executive Director at Wuxi Biologics (Cayman), Inc. since 2012 and at WuXi XDC Cayman, Inc. since 2020.
Previously, he held positions as an Associate Director at Merck & Co., Inc. from 1994 to 2002, a Senior Director at Genzyme Corp.
from 2008 to 2012, and a Senior Director at PDL BioPharma, Inc. from 2002 to 2008.
He obtained a doctorate degree from the University of Hannover in 1989 and an undergraduate degree from Jiangxi University of Science & Technology in 1982.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/06/2024 | 483 419 ( 0,01% ) | 714 532 $ | 30/06/2024 |
Postes actifs de Wei Chang Zhou
| Sociétés | Poste | Début |
|---|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | Directeur/Membre du Conseil | 01/05/2016 |
| WUXI XDC CAYMAN INC. | Directeur/Membre du Conseil | 01/12/2020 |
Anciens postes connus de Wei Chang Zhou
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/12/2012 |
| PDL BIOPHARMA, INC. | Directeur/Membre du Conseil | 01/02/2008 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/10/2002 |
Formation de Wei Chang Zhou
| Jiangxi University of Science & Technology | Undergraduate Degree |
| University of Hannover | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| WUXI XDC CAYMAN INC. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
